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ABSTRACT: Linking cellular toxicity to low-tier animal toxicity and beyond is crucial
within the adverse outcome pathway concept and the 3R framework. This study aimed to
determine and compare the bioavailable effect concentrations in zebrafish cell lines and
embryos. Acute, short-term toxicity (48 h) of eight veterinary pharmaceuticals was
measured in two zebrafish cell lines (hepatocytes, fibroblasts) and zebrafish embryos. Seven
endpoints of cytotoxicity were recorded. The fish embryo acute toxicity test was modified by
adding sublethal endpoints. Chemical distribution modeling (mass balance) was applied to
compute the bioavailable compound concentrations in cells (Cfree) and embryos (Cint;aq)
based on nominal effect concentrations (Cnom). Effect concentration ratios were calculated
(cell effects/embryo effects). A low correlation was observed between cytotoxicity and
embryo toxicity when nominal concentrations were used. Modeled bioavailable effect
concentrations strongly increased correlations and placed regression lines close to the line of unity and axis origin. Cytotoxicity
endpoints showed differences in sensitivity and predictability. The hepatocyte cell line depicted closer proximity to the embryo data.
Conclusively, the high positive correlation between the cell- and embryo-based test systems emphasizes the appropriate modulation
of toxicity when linked to bioavailable concentrations. Furthermore, it highlights the potential of fish cell lines to be utilized in
integrated testing strategies.
■ INTRODUCTION
Toxicological risk assessment and regulatory decision making,
such as the REACH directive,1 TSCA reauthorization,2 and
others,3−6 have collaterally increased animal testing,7,8 a
development contradictory to efforts made to reduce, replace,
and refine (“3Rs”)9 the usage of animals for both human
toxicology10−12 and ecotoxicology.13,14 Given that we live in an
ever-growing chemical environment, the plethora of xenobiotic
compounds surrounding us needs to be assessed in ethically
and economically feasible ways.15 New approach methods
(NAMs) consisting of in vitro (i.e., cell-based test systems) and
in silico (computer models) techniques have the potential to
assess a large number of compounds10 given their compatibility
with omics technologies, high-throughput screenings (HTS),
and the adverse outcome pathway (AOP) concept.16 Cellular
in vitro techniques are optimal sentinels for recording
molecular initiating events (MIEs) and lower-tier key events
(KEs) within the AOP concept but are lacking regulation-
relevant apical endpoints.
Within ecotoxicology, the fish embryo acute toxicity test
(“FET”, OECD 236)17 highlighted a significant turning point
in the implementation of alternative methods. In the European
Union, zebrafish embryos demand no ethical permission until
120 h postfertilization (hpf)18 (onset of independent feeding),
meaning that the FET assay is legislatively defined as an in vitro
assay; biologically, it can be regarded as in vivo, especially at
120 hpf. Zebrafish embryos can be used in an HTS manner, as
phenotypical changes are easily observed due to their
transparency. Within the AOP concept, the FET can be
utilized for the characterization of higher-tier KEs and adverse
outcomes (AOs). Noteworthily, the nominal effect concen-
trations between the FET and the acute fish toxicity test
(“AFT”, OECD 203)19 are highly correlative20−22 and
measurements of lethal apical endpoints at 96 hpf are proposed
to be an accurate surrogate to the AFT data. However, how
well effect measurements from the FET correlate to those from
cell-based assays is less studied, which is essential for bridging
the in vitro to in vivo gap within the AOP concept. Therefore,
the FET can be employed as a connecting platform (Figure 4).
Fish cell lines are genuine non-animal alternatives in
ecotoxicology.13 Several authors considered the use of fish-
derived cytotoxicity assays as alternatives to in vivo assays
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(reviewed in Castaño et al.23). Schirmer et al. proposed the use
of fish cell lines in regulatory testing of chemicals and
effluents.24 The latest efforts in this regard culminated in the
publication of the rainbow trout (Oncorhynchus mykiss) cell
line assay (RTgill-W1 cells) for predicting acute fish toxicity as
an ISO guideline.25,26 In general, cell-based assays display
lower sensitivity than in vivo techniques when comparing
nominal effect concentrations (Cnom)
27−30 (see Table S1 for
concentration nomenclature). The difference in sensitivity
might be explained by the reduced or nonexisting xenobiotic
metabolism, lower level of biological complexity, and reduced
bioavailability of exposure compounds.31 Especially the latter is
predominantly due to differences in experimental conditions32
given that fish and fish embryos are exposed in water, whereas
cells are grown in complex cell culture media. The latter
contain serum, protein, and lipids that act as sinks for
hydrophobic compounds33−36 (especially at log Kow > 3).
32
Thus, the actual bioavailable concentration to the cells, the free
concentration (Cfree), is only a fraction of Cnom. Contextually,
antecedent attempts at comparing toxic potencies between fish
cells and whole fish test systems resulted in weak
correlations.37
Two principal strategies emerged to address a weak
correlation due to bioavailability differences between test
systems. The first is by measuring the real exposure
concentrations via chemical analysis. Tanneberger et al. and
Natsch et al. successfully conducted such an approach in the
RTgill-W1 cell line,38,39 indeed showing an improved
correlation. However, extraction and chemical analysis are
time-consuming, are costly, and hamper high-throughput
testing of chemicals. The second strategy relates to modeling
bioavailable concentrations as a better dose metric for
biologically effective concentrations. By using chemical
distribution models (mass-balance model, “MBM”), differ-
ences in chemical partitioning between lipids and proteins are
accounted for, increasing the comparability of biologically
effective concentrations between test systems. Recently,
appropriate MBMs were developed for cell-based assays40
and the FET.41 Generally, modeling has the advantage of
omitting extraction and chemical analysis, making it a
considerably more straightforward approach.31
Recently, Rodrigues et al. claimed high correlations in
nominal effect concentrations for pharmaceuticals42 but not for
pesticides43 when comparing cytotoxicity data derived from rat
cardiomyoblasts and the literature with AFT data. The
pesticide study caused subsequent controversies,44,45 thus
highlighting the topicality and importance of the issue.
Additionally, Villeneuve et al. recently reviewed the state of
the science in environmental high-throughput screening,46 and
they proposed the assessment of bioavailable concentrations in
cells (Cfree) and fish (Cint) for a proper comparison and
correlation.
This study aimed to compare the acute, short-term toxicity
between two permanent zebrafish (Danio rerio) cell lines
(hepatocytes, fibroblasts) and the zebrafish embryo. We
hypothesized that the cell-derived cytotoxicity data correlate
appropriately with the modified-FET (mFET) data when
modeled bioavailable effect concentrations are considered
instead of nominal effect concentrations. To this end, we
generated acute toxicity data for eight veterinary pharmaceut-
icals, covering different compound classes. We employed the
MBMs developed by Fischer et al.40 for the cell lines and by
Bittner et al.41 for the mFET assay and evaluated the nominal
and modeled bioavailable effect concentrations.
■ MATERIALS AND METHODS
A detailed description of all relevant materials and methods is
given in the Supporting Information 1, Section 1.1. The
important aspects are condensed in the following:
Eight veterinary pharmaceuticals were purchased from
Sigma-Aldrich, Steinheim, Germany (albendazole (Abz),
doramectin (Dor), febantel (Feb), fenbendazole (Fen),
flumethrin (Flu), ivermectin (Ive), oxfendazole (Ox), and
toltrazuril (Tol); all >95% purity, Supelco or VETRANAL
analytical standards).
ZF4 (fibroblasts) and ZFL (hepatocytes) cell lines were
purchased from ATCC (Manassas, VA, USA). The culturing
procedures are described in the Supporting Information 1,
Section 1.1.2 and prior publications.47,48 The cells were
exposed to eight increasing concentrations of the veterinary
pharmaceuticals. Exposure ranges were defined in pilot
experiments. After 48 h of exposure, seven different endpoints
of cytotoxicity (in vitro biomarker of toxicity) were recorded
via three different multiplex assays. NAD(P)H metabolism and
protein amount were recorded using the dimethylthiazol-
tetrazolium salt (MTS) and bicinchoninic acid (BCA)
multiplex assay. ATP metabolism and membrane stability
were recorded using the adenosine triphosphate (ATP) and
lactate dehydrogenase (LDH) multiplex assay.48,49 Aerobic
cellular respiration and membrane and lysosome stability were
recorded using the alamarBlue (AB), carboxyfluorescein
diacetate acetoxymethyl ester (CFDA), and neutral red (NR)
multiplex assay. The AB/CFDA/NR multiplex assay was
conducted according to the Schirmer group26,50−53 with
alterations made by Bopp and Lettieri54 and ourselves to
employ serum-mediated passive dosing.55,56 Both absorbance
(NRa) and fluorescence (NRf) were recorded for the NR
endpoint. Nominal median inhibitory concentrations
(IC50;nom) (Table S1) of the cytotoxicity endpoints were
computed by a four-parameter log-logistic regression, with
alternations described by Weimer et al.57 and plotted in
GraphPad Prism 8 (GraphPad Software, La Jolla, CA, USA).
For the zebrafish embryo data, methodologies and results of
the modified fish embryo test (mFET; addition of sublethal
endpoints to standard FET apical endpoints) after 144 h of
exposure are described in detail in Carlsson et al.58 and the
Supporting Information, Sections 1.1.5−6. For this study, the
raw data at 48 hpf were retrieved and analyzed. Nominal
median effect concentrations (EC50;nom) of the embryo toxicity
were computed by probit regression and plotted using Minitab
18.1 (Minitab Inc., State College, PA, USA).
Chemical distribution models (mass-balance model,
“MBM”) were applied to derive the bioavailable concen-
trations and protein/lipid-bound fractions. The Fischer et al.40
MBM was used to compute the respective bioavailable median
concentrations in the cell lines (IC50;free), whereas the Bittner et
al.41 MBM was used for the embryo (IAEC50). Distribution
coefficients of all veterinary pharmaceuticals between relevant
phases, as they are mandatory for the MBM input, were
obtained via the UFZ-LSER tool59 (Supporting Information 2,
sheet “LSER”).
IC50;nom and IC50;free were divided by EC50;nom and IAEC50,
respectively, to display the potency ratios. Nominal and
bioavailable median effect/inhibitory concentrations were log-
transformed, tested for normality by Shapiro−Wilk and
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Kolmogorov−Smirnov tests (P = 0.05), and analyzed graphi-
cally by a normal q−q plot. Pearson correlation coefficients
between all cell- and embryo-derived data were computed
(Supporting Information 2, sheet “correlation”), and adjusted
R2 values were illustrated in heatmaps. Deming (Model II)
linear regression was performed to obtain regression equations
(Supporting Information 2, sheet “regression”). Statistical
testing and plotting were conducted with GraphPad Prism 8.
■ RESULTS AND DISCUSSION
Within ecotoxicology, there is an ongoing debate as to what
extent are cellular in vitro systems a feasible approach in
toxicity testing and risk assessment. There still seems to be
uncertainty in using nominal concentrations rather than
bioavailable concentrations, as demonstrated in the Rodrigues
et al. controversies.44,45 In this study, we first demonstrated
how modeling bioavailable effect concentrations strongly
increased the correlation between zebrafish cell lines and
embryo-derived data for the eight tested veterinary pharma-
ceuticals. We then tested if the approach improved the
correlation for pesticides, as utilized by Rodrigues et al.
Acute Toxicity in Zebrafish Cells. Seven different
endpoints of cytotoxicity were recorded after exposure to
eight veterinary pharmaceuticals comprising different classes of
organic compounds (Table S2;Supporting Information 2, sheet
“properties”). A four-parameter log-logistic regression with
additions, according to Weimer et al.,57 was performed to
compute respective IC50;nom (Figures S4−S19; Table S3;
Supporting Information 2, sheet “cell data”). Note that the
lactate dehydrogenase (LDH) endpoint was excluded from
further analyses given that the response data were poorly
described by the log-logistic regression model, as indicated by
the low adjusted R2 and high normalized RSME values, most
likely due to the nonmonotonous concentration−response
characteristics (Table S3; Figures S4−S19, panel D). A more
detailed discussion of the latter is given in Supporting
Information 1, Section 2.2. The tested compounds depicted
a range of potencies with the mean log IC50;nom spanning from
−3.64 (Flu) to −5.62 (Fen) log[M] (Figure S21). Some
compounds (Dor, Feb, Flu, Ive, Tol) showed less, whereas
others (Abz, Fen, Ox) showed more scattered (log) IC50;nom
values (Figure S21; Supporting Information 2, sheet “cell
data”). The pattern is also represented in the potency ratios of
the nominal median concentration (IC50;nom/EC50;nom), which
are discussed further below (Figure 1A).
When comparing IC50;nom values between different cytotoxic
endpoints, the BCA endpoint seemed to be the most sensitive,
whereas the CFDA endpoint was the least sensitive (Figure
S21). However, the pattern is not consistent with BCA-ZFL,
being the least sensitive endpoint after flumethrin exposure,
and might thus derive from technical abnormalities. On the
contrary, Natsch et al. found the CFDA endpoint to be the
most sensitive out of the AB/CFDA/NR-triplex assay39 when
testing the acute toxicity of fragrance chemicals. However, the
authors regarded the differences in sensibility as negligible
given that all three endpoints were highly intercorrelated. The
endpoints of energy metabolism (MTS-ZFL, MTS-ATP) are
more sensitive in the ZFL cell line exposed to albendazole
(Figure S21A) and fenbendazole (Figure S21D). However, this
was not confirmed for the ZF4 cell line. The other cytotoxicity
endpoints are located close to their respective log IC50;nom
means. Conclusively, we would mostly recommend the AB/
CFDA/NR-triplex assay26 given its applicability, the total
number of scored endpoints, and its overall sensitivity and
correlation. The relationship of cellular cytotoxicity endpoints
to apical endpoints of the mFET is discussed further below in
more detail.
Supposedly, compounds might operate via different modes
(MoAs) and mechanisms of action (MOAs) and are therefore
impacting endpoints differently, leading to diverse patterns of
Figure 1. Potency ratios of median inhibitory concentrations of the
cellular cytotoxicity assays vs median effect concentrations of the
mFET assays (IC50;x/EC50;x). The ratios are plotted as an endpoint of
cellular toxicity per tested compound. Potency ratios are based on
nominal concentrations (A; IC50;nom/EC50;nom), modeled free
concentrations (B; IC50;free/EC50;nom), or modeled internal concen-
trations (C; IC50;free/IAEC50). The median value of all compounds per
endpoint is marked with a green line and depicted above the x axis.
The line of unity at 100 = 1 is marked with a red line; ± 1 order of
magnitude deviations are marked with dotted red lines.
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sensitivity. Compounds with narrow endpoint distributions
and similar IC50;nom values (Table S3; Figure S21; Supporting
Information 2, sheet “cell data”) may display the same MOA,
most likely baseline toxicity (narcosis), whereas compounds
with broad endpoint distributions may display a range of
distinct MOAs that are differentially reflected in the tested
endpoints. Neurotoxins were reported to induce baseline
toxicity in RTgill-W1 cell lines.38 The neurotoxin flumethrin
had the lowest overall toxic potency in the cell lines.
Contrarily, the other neurotoxins (Dor, Iver) displayed
stronger toxic potencies than some of the tested benzimida-
zoles (Feb, Ox), which have a specific MOA in target
organisms (Table S2). Thus, neither MOAs nor MoAs are
conserved in nontarget organisms, especially not in the cell
lines. Some of the compounds (Feb, Flu, Tol) might be
considered to be acting via a baseline toxicity MOA, whereas
the others (Abz, Dor, Fen, Iver, Ox) have different MOAs in
the cell lines. However, no realistic interference can be made
by the generated patterns or used compound classes, especially
not in an MoA manner, which was also not the intention of the
conducted study.
The IC50;nom values for five out of the eight tested
compounds (Abz, Dor, Feb, Fen, Ox) were compared to
available CompTox bioactivity data (https://comptox.epa.
gov/dashboard/) to check for data integrity. Mammalian
data validated the zebrafish cell line results (Supporting
Information 2, sheet “cell data”) and correlated well in
qualitative terms. More detailed information is given in
Supporting Information 1, Section 2.4.1.
Acute Toxicity in Zebrafish Embryos. The effects of the
eight veterinary pharmaceuticals on the zebrafish embryo have
been discussed in detail in Carlsson et al.58 for the 144 hpf time
point. The median effect concentrations (EC50;nom) at 48 hpf
that were extracted from the original data and computed for
this study (Figure S20; Supporting Information 2, sheet
“mFET data”) differed in comparison to those at 144 hpf. For
some compounds, EC50;nom is approximately the same between
time points (Abz, Fen, Flu, Ox), whereas for the others, the
difference in toxicity is approximately 10-fold (Dor, Feb, Ive,
Tol), with the 48 hpf time point being one log-scale less
sensitive. The toxicity differences between time points might
be due to bioaccumulation (enhanced uptake due to chorion
detachment), bioactivation, or different susceptible devel-
opmental windows.60,61 In terms of potency, the EC50;nom
values, derived from the apical and sublethal endpoints in
the mFET, depict a wide range from −7.11 log[M] (Fen) to
−4.61 log[M] (Ox) (Table S4; Figure S22).
A survey was conducted in the Ecotox database (https://
cfpub.epa.gov/ecotox/search.cfm) to check the integrity of the
fish embryo data. Unfortunately, comparable data were only
retrieved for ivermectin. Two other studies showed propor-
tionate EC50;nom values at 48 and 144 hpf in zebrafish embryos
and larvae.62,63 For all other compounds, no fish-related data
were found; only studies in plants or invertebrates are
available.
Nominal Median Effect/Inhibitory Concentrations:
Cell Lines vs Embryo. When comparing EC50;nom values
(embryo) to IC50;nom values (cells), there is a general 10-fold
(one log-scale) difference in sensitivity between the embryo
and cell test systems, with the compounds showing higher
potency in the mFET (Table S5; Figure S23). Three
compounds differ from the general pattern. Flumethrin and
fenbendazole are two to three log-scales more sensitive in the
mFET, whereas oxfendazole shows equal nominal median
concentrations between test systems. Flumethrin took on a
particular position. For flumethrin, only the sublethal
endpoints were recorded in the mFET assay (Figure S20E),
and the probit regression model fit was suboptimal (Table S4).
Additionally, flumethrin displays the highest logKow (6.97, see
Table S2) of all tested compounds. In terms of nominal
concentrations, flumethrin shows the lowest toxicity in the
cytotoxicity assays (Figure 1A; Figure S21E) and deviates the
strongest from the calculated regression lines (Figure 3A).
Hence, we decided to also display the data without flumethrin
(respective graphs in Supporting Information 1), considering
that it might be due to technical incompatibilities.
We calculated the potency ratios (IC50;x/EC50;x) for nominal
effect/inhibitory concentrations (Figure 1). The potency ratios
are a measure of the test system’s sensitivity: ratios of
compounds depicting a higher potency in the mFET assay are
located above the line of unity, and ratios depicting a higher
potency in the cytotoxicity assays are located below the line of
unity. As for the numeric median concentrations, we see an
approximately 10-fold difference in potency (Figure 1A; Figure
S22A) with similar outliers (Ox, Flu), thus indicating major
differences to the other compounds in toxicokinetic and
toxicodynamic perspectives.
The median potency ratio value of oxfendazole (1.51; Figure
1, green line) is almost on the line of unity, with more than half
of the endpoints’ potency ratios being more sensitive in the
cell-based assays. Besides that, only the BCA endpoint
measured for cells exposed to albendazole is more sensitive.
Correspondingly, Gülden and Seibert29 reported minor
differences in nominal effect concentrations between in vitro-
and in vivo-derived effect concentrations for less cytotoxic
compounds. For compounds with a low cytotoxic potency, the
reduction in bioavailability due to binding to medium
ingredients was less significant because binding might be
saturated at the chemical concentration needed to elicit
toxicity. Accordingly, oxfendazole caused the lowest toxicity in
the mFET assay (Table S5; Supporting Information 2, sheet
“mFET data”), explaining the good correlation already for
Cnom.
Flumethrin deviates largely in nominal median inhibitory/
effect concentrations between cells and embryos (Table S5;
Figure S23A). The potency ratio median (Figure 1A) is 698-
fold less sensitive in the cell-based assays and for one endpoint
(BCA-ZFL) even 10,000-fold. The presence of tremors in the
embryos (sublethal endpoint) accounted for most of the
recorded effects. The latter reflects flumethrin’s potential
neurotoxic mode of action (MoA) in the mFET. Arguably,
flumethrin might act as a neurotoxin in the fish embryo already
at 48 hpf as this observation is similar to the 144 hpf time
point58 (Figure S25A). The FET has been reported to be less
sensitive to neurotoxins in comparison to the AFT.21 RTgill-
W1 cells showed reduced sensitivity to neurotoxins in
comparison to in vivo data.38,64 The detection of neurotoxicity
in the embryo test is, however, due to the inclusion of sublethal
endpoints (mFET). This effect would not have been recorded
if only the standard lethal endpoints described for the FET
test17 were used. Since an adequate in vitro assessment of
neurotoxins requires neural cells expressing particular intrinsic
transporter and membrane receptor proteins (e.g., dopaminer-
gic and glutamatergic),65 permanent fish fibroblasts (ZF4) and
hepatocytes (ZFL) are not appropriate. Beyond that,
flumethrin has the lowest water solubility of all tested
Environmental Science & Technology pubs.acs.org/est Article
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compounds (5.95 × 10−07 M; Table S2). Potentially, in an
aqueous environment, maximally solved concentrations before
precipitation are not high enough to cause a baseline toxicity
effect, which is most likely recorded here with the cellular
assays (range from 2.41 × 10−07 to 6.13 × 10−03 M). However,
as mentioned previously, apical endpoints within the mFET
and nonspecific cytotoxicity endpoints, as recorded in the cell
lines, do not bare sufficient mechanistic information to draw
potential conclusions on specific MOA and MoA.
Pearson-derived correlations between IC50;nom and EC50;nom
values (Figure 2) were weak and statistically nonsignificant for
both cell lines as well as the pooled cytotoxicity data (adj. R2
range from 0.02 (BCA-ZFL) to 0.46 (NRa-ZF4); see also
Supporting Information 2, sheet “correlation”). If flumethrin
was excluded, overall correlations were increasingly compelling
(R2 = 0.96 (NRa-ZF4), Figure S26). However, since the
dataset gives no insights into the mechanisms of toxicity, such
an exclusion remains tentative. Nevertheless, the potential
exclusion of flumethrin indicates how bioavailability potentially
modulates toxicity given that flumethrin depicts the most
substantial discrepancy in terms of nominal concentrations
(Figure S23A). Generally, the correlation coefficients are
higher for ZF4 than for ZFL. Notably, the ZF4 nutrition
medium contains double the amount (10%) of FBS than ZFL
(5%). A higher amount of FBS in the nutrition and exposure
medium has been reported to be associated with enhanced
uptake kinetics in cells.55 Thus, the equilibrium at the target
site might be reached earlier in a high-FBS scenario, leading to
a more sensitive measure of the nominal median concen-
tration. Nevertheless, since both FBS concentrations used are
relatively high, uptake kinetics-mediated effects might be
marginal within a 48 h exposure regime. Hence, other factors
such as cell line origin, overall density, and mass or general
biological sensitivity might be crucial.
Bioavailable Median Effect/Inhibitory Concentrations
Increased Goodness-of-Fit: Cell Lines vs Embryo. We
hypothesized that modeling bioavailable median effect/
inhibitory concentrations (IC50;free; IAEC50) would signifi-
cantly increase the correlation between the cell- and embryo-
derived data. To test our hypothesis, we applied two state-of-
the-science MBMs to estimate the bioavailable concentrations
for the cells40 and the embryo.41 Noteworthily, these chemical
distribution models are based on empirical protein and lipid
content data derived from the fish embryos and cell culture
media.
Modeling the bioavailable concentration in the medium
(Cfree) according to Fischer et al.
40 (Supporting Information 2,
sheet “Model Fischer2017”) disclosed an increased potency of
the cell-derived measures (Figure 1B; Figures S21 and S23).
Accordingly, Kramer et al.30 observed the nominal effect
concentrations being approximately 10-fold higher than the
bioavailable effect concentration for phenanthrene in Balb/c
3T3 and RTgill-W1 cells. For six out of the eight tested
compounds (Abz, Dor, Feb, Fen, Flu, Iver), the modeled
bioavailable concentrations differed statistically from the
nominal concentrations (Figure S21). The bioavailable
concentrations for fenbendazole and flumethrin differed by
more than one log-scale. Oxfendazole and toltrazuril barely
showed any differences between the nominal and bioavailable
inhibitory concentrations. Modeling the bioavailable aqueous
internal effect concentration (Cint;aq) according to Bittner et
al.41 did not indicate significant alternations in compound
potencies, except for toltrazuril (Figure S22).
Cfree of fenbendazole and flumethrin showed the highest
discrepancies to Cnom. It is evident how binding to medium
components drastically reduces their bioavailability within the
in vitro systems. Once the actual bioavailable concentrations
are computed and related to the bioavailable concentrations in
the mFET system, the differences in sensitivity and potency are
relatively small. We discussed that IC50;nom and EC50;nom of
oxfendazole were already showing a high similarity, most likely
due to hydrophilicity. Thus, Cnom and Cfree are practically equal,
and the culture medium ingredients are only marginally
affecting the bioavailability. Toltrazuril was the only tested
zwitterionic compound that is not >99% encountered in its
neutral form at physiological pH (Supporting Information 2,
sheet “Model Bittner2019”). Given that toltrazuril has the
lowest pKa value (6.47) of all tested compounds, it will likely
have a representative amount of ionized species at physio-
logical pH. In an aquatic environment, toltrazuril will
bioconcentrate to a lesser extent than the other compounds.66
Ionic species feature different sorption preferences than neutral
organic compounds, as they increasingly partition into
phospholipids and structural protein,67 and they are suscep-
tible to an ion-trapping effect if the pH of the exposure
medium is lower than the internal pH of the organism.66
Regarding the IC50;free/EC50;nom comparison, median po-
tency ratios are located underneath the upper 10-fold
borderline and close to the line of unity for all compounds
and endpoints (0.21−6.01; Figure 1B; Figure S24B). As above,
the median potency ratios remained almost equal for the
IC50;free/IAEC50 comparison but also with toltrazuril almost
located on the line of unity (1.63; Figure 1C). The differences
in sensitivity between test systems and potencies of
compounds are rather negligible once the actual bioavailable
effect/inhibitory concentrations are considered. Interestingly,
the differences between Cnom and Cint;aq were more
pronounced in the ZF4 cell line. As stated above, ZF4 uses
Figure 2. A heatmap of adjusted R2 values derived from Pearson correlation of the various ICx (cells) vs ECx (fish embryos) comparisons per
endpoint of cellular toxicity. Correlations of nominal and bioavailable median concentrations are depicted for ZFL, ZF4, and pooled cell lines
(column stacks). For significance levels and P values of Pearson correlations, see also Supporting Information 2, sheet “correlations”. Additionally, a
correlation heatmap without flumethrin and without neurotoxins is available in Supporting Information 1 (Figure S26).
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twice the amount of FBS as ZFL; sorption to structural
protein, mostly within the serum, is expected for ionic
chemicals. Accordingly, the bioavailable effect/inhibitory
concentrations are appropriately represented after the
modeling procedures.
The similarity in bioavailable effect/inhibitory concentra-
tions between the two test systems is further reflected in the
computed Pearson correlations (Figure 2) when comparing
the nominal concentration arrangement (IC50;nom vs EC50;nom)
against the bioavailable concentration arrangements (IC50;free
vs EC50;nom; IC50;free vs IAEC50), with adj. R
2 up to 0.89 (NR
endpoints in ZF4). The Pearson correlations are even further
increased when specific data are omitted, e.g., without Flu and
without neurotoxins, with adj. R2 up to 0.99 (NRa-ZF4; Figure
S26). However, as already mentioned, such an exclusion
remains tentative given that mechanistic exclusions cannot be
made with the dataset at hand. According to the potency ratios,
Cint;aq had barely any impact on the correlations (IC50;free vs
IAEC50), with some endpoints showing marginally higher or
lower values. This reflects well how the bioavailable
concentrations differ only for toltrazuril from the nominal
concentrations in the mFET system. Overall, the ZFL cell line
shows a better fit for the embryo-derived data, the NR
endpoints correlate best, and the BCA and CFDA endpoints
have the lowest correlations for all the nominal and
bioavailable concentrations.
Type II linear regression (Deming) was conducted to
identify goodness-of-fit between the cell- and embryo-derived
concentrations. The results are shown in Table S6 for the
entire dataset and illustrated in Figure 3 for the pooled NRa
endpoint. The NRa endpoint for pooled cell lines depicted the
overall strongest correlations (Figure 2), and its regression
analyses showed statistically significant deviation from zero in
all tested setups (P < 0.05; Table S6). Therefore, the latter was
plotted here in detail (Figure 3). Cnom (Figure 3A) shows
rather low correlations (adj. R2 = 0.33); e.g., the flumethrin
values are remotely located from the regression fit ( f(x) =
0.82x − 0.11). For Cfree, the fit for NRa-pooled increases (adj.
R2 = 0.88; Figure 3B) as well as for all other endpoints tested,
with all setups becoming statistically significant except for
CFDA-ZF4, CFDA-ZFL, and BCA-ZFL (P < 0.05; Table S6,
data not illustrated graphically). Above, we described how
considering Cint;aq only marginally altered correlations.
However, Figure 3C illustrates how the goodness-of-fit is
influenced by also regarding the bioavailable concentrations in
the mFET system. Now, the regression line is almost on par
with the line of unity ( f(x) = 1.1x + 0.68). This holds true for
the depicted endpoint as well as every other recorded endpoint
and setup (Table S6). In parallel to the calculated Pearson
correlations, when omitting certain data, correlation and fit are
further enhanced (Figure S29). Conclusively, the Deming
regression analysis proved how Cfree and Cint;aq relate between
both investigated test systems, nearly to the point of absolute
unity.
Internal and Structural Lipid Median Effect/Inhib-
itory Concentrations: Cell Lines vs Embryo. We intended
to investigate as to what extent the total internal concen-
trations (Ccell vs Cint) and internal partitioning to structural
lipid (Cmem vs Cint;lip) would correlate. Consequently, we
modeled the internal cellular concentration (Ccell) and cellular
membrane concentration (Cmem) in the cytotoxicity assays by
using the Fischer et al.40 model. Furthermore, we modeled the
total internal concentration (Cint), the critical membrane
concentration (Cint;lip), and the internal protein-bound
concentration (Cint;prot) in the zebrafish embryo via the Bittner
et al.41 model.
Unexpectedly, correlations and predictions are less prom-
inent as for the bioavailable concentrations (Table S7; Figure
S27; Supporting Information 2, sheets “correlation” and
“regression”), with adj. R2 values ranging from 0.27 (IC50:cell/
IEC50, BCA-ZF4) to 0.86 (IC50:mem/IEC50;lip, MTS-ZF4).
Figure 3. Deming regression of depicted ICx (cells) and ECx (fish
embryo) values for pooled cell lines (ZF4 + ZFL) and the NRa
(neutral red, absorbance) endpoint of cellular toxicity. The regression
line is plotted in solid black, the line of unity is in solid red, and 1
order of magnitude deviations from the line of unity are plotted as
dotted red lines. Regression equations and adjusted R2 values of
Pearson correlations are given for every setup of comparison.
Significant positive linear relationships were found for all setups
depicted here (for the total dataset, see also Table S6): log IC50;nom vs
log EC50;nom (A), log IC50;free vs log EC50;nom (B), and log IC50;free vs
log IAEC50 (C).
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Nevertheless, only 6 out of the 42 tested arrangements did not
show statistical significance for correlations (P < 0.05).
Previous studies also encountered varying predictions between
internal fish and internal cell concentrations, which most likely
occur due to differences in toxicokinetics between the
investigated biological systems.64 Moreover, various studies
recommended to compare modeled or measured in vitro Cfree
to nominal in vivo effect concentrations (ECnom or LCnom) or, if
available, unbound plasma concentrations.31,40,68−70 While
applying the Bittner et al.41 model, we decided to use the
Cint;aq metric for comparison given that the internal aqueous
concentration resembles the unbound and bioavailable fraction
of the compounds in fish embryos best and thus mimics Cfree in
the cell-based assays.
Noteworthily, none of the used biological and physicochem-
ical parameters in the models had been measured, but all were
derived from literature and average values. Still, the latter
conceptually proves the robustness of the models to predict
bioavailable effect concentrations even without precise
parameter detections. Theoretically, precise parameter meas-
urements would further rectify this issue, fitting the
correlations and regressions closer to unity. Reasonably,
empirical parameters should be recorded for cellular systems
to be used in future HTS.
In Vivo Considerations: mFET 144 hpf Time Point. For
the eight veterinary pharmaceuticals, Carlsson et al. recorded
adverse effects up to 144 hpf58 (Supporting Information 2,
sheet “mFET data”). We used the latter to compute Cint;aq at
144 hpf to compare with estimates at 48 hpf. Hence, it might
be vital to claim that we are comparing in vitro cellular
concentrations to in vivo fish embryo concentrations, especially
when including the 144 hpf values, which are around the start
of independent feeding. However, the mFET beyond 120 hpf
has to be interpreted as a low-tier in vivo system given that
both toxicokinetic and toxicodynamic processes are not equal
to adult fish60 and might deviate for some compounds from
AFT data.71
Median potency ratios at 144 hpf are mostly comparable to
48 hpf, and changes in patterns due to bioavailability are
identical (Figure S25). Doramectin, ivermectin, and toltrazuril
are marginally more toxic in the mFET assay at 144 hpf as
compared to 48 hpf. An extended exposure period might lead
to accumulated adverse effects. Beyond that, the zebrafish
embryo is encapsulated within a chorion until approximately
72 hpf. The chorion might act as a barrier as well as a structural
sink for lipophilic compounds and therefore might alter uptake
kinetics.60,61 Alternatively, most of the tested compounds were
reported to drop in measured concentrations at 144 hpf58 due
to metabolization. Bioactivation of metabolites might lead to
increased toxicity. Febantel shows an approximately fivefold
increase in toxicity between 48 and 144 hpf. Carlsson et al.58
demonstrated the metabolization of febantel into fenbendazole
and further into oxfendazole within the embryo. Fenbendazole
induces toxicity at lower concentrations compared to febantel
(Figure S21; Supporting Information 2, sheets “cell data” and
“mFET data”). Therefore, the shift in potency might be due to
the metabolism-derived bioactivation of febantel. Accordingly,
Pearson correlations are slightly lower between in vitro and in
vivo data at 144 hpf compared to 48 hpf (Figure S28). The
latter phenomenon could be reverted by including a metabolic
activating system (liver microsomes) to the cytotoxicity assays,
as has been done elsewhere for the FET.72
Studies have shown that the sensitivity to a compound does
not increase substantially at 24 hpf in the FET.20,21 However,
the latter statement does not apply to all compound
classes,22,71 which is still being reflected in very high
correlations in certain arrangements that are omitting specific
sources (IC50:free vs IAEC50 in NRf-ZF4: adj. R
2 = 0.93).
Conclusively, we postulate, at least for the compounds tested
in this study, that cytotoxicity measurement in zebrafish cell
lines is an appropriate predictor of AFT toxicity if the FET is
considered as a bridging platform (Figure 4).
Approach Verification to Show the General Applic-
ability. Rodrigues et al. compared the nominal effect
concentrations of AFT data to cytotoxicity data derived from
Figure 4. Fish embryo test (FET), and therefore fish cytotoxicity assays, can be used as a bridging technology in integrated test strategies (ITS) for
the correlation of in vivo acute toxicity data until appropriate quantitative in vitro to in vivo extrapolation (QIVIVE) is also available in an
ecotoxicological context. The illustration was generated in the licensed BioRender application.
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rat cardiomyoblasts and data from the literature. They found
good correlations for the investigated group of pharmaceut-
icals42 but not for the investigated group of pesticides,43 which
caused subsequent controversies regarding their conclu-
sions.44,45 Our data reflect the pesticide study quite well,
with compounds showing a broad range of potencies, regarding
the induction of cytotoxicity. We define the tested compounds
in regard to their utilization as veterinary pharmaceuticals, but
in terms of their classes, they could also be defined as
pesticides. In this context, we postulate that most of the effects
in the Rodrigues et al. pesticide study would correlate stronger
between in vitro and in vivo if proper modeling of their
bioavailable concentrations were applied.
To prove our postulation, we modeled the bioavailable effect
concentrations of a set of compounds from the Rodrigues et al.
pesticide study (10 additional compounds, 5 additional
compound classes; see Supporting Information 2, sheet
“properties”) and conducted comparisons in the same manner
as for our dataset. Further details are given in Supporting
Information 1, Section 2.6. In summary, the bioavailable effect
concentrations of the in vitro data correlated appropriately to
the in vivo data (R2 = 0.65; Figure S30). We speculate that a
measured or modeled unbound plasma concentration in the
fish would further improve the correlations; e.g., our forward
dosimetry approach could be combined with a reverse
dosimetry approach in vivo, as conducted previously for AFT
data.64,73,74 When FET data were correlated to the in vitro data
instead of AFT data, the correlation fit nearly located on the
line of unity (R2 = 0.75; Figure S31), as with our dataset.
Conclusively, we assume that the above-named authors would
have reasoned differently if bioavailable concentrations were
applied originally. We are not questioning the outcome and
integrity of the above-stated studies, but we are advocating the
use of appropriate concentration measures when attending the
prediction of acute in vivo toxicity from in vitro cytotoxicity.
■ OUTLOOK AND PERSPECTIVES
In vitro to in vivo extrapolation (IVIVE) has been termed “the
philosopher’s stone” of in vitro toxicology.75 IVIVE describes
the qualitative or quantitative transposition of effects recorded
in vitro to predict toxic exposure levels in vivo.76,77 Therefore, it
belongs to a new test strategy to replace animal testing in
toxicology and is part of a battery of methods to estimate toxic
exposure levels using non-animal tests. A quantitative IVIVE
(QIVIVE) is a holistic approach to in vivo exposure level
prediction, combining in vitro and in silico techniques (NAMs),
such as quantitative structure−activity relationship modeling
(QSAR) and physiologically based toxicokinetic/dynamic
modeling (PBTK/TD)78−80 (Figure 4). PBTK/TD models
need, e.g., reliable in vitro biotransformation, distribution, and
absorption-defining (ADME) test systems to be developed and
evaluated.78 Such test systems are scarce in ecotoxicology, and
most test systems cover only the evaluation of nonspecific
toxicity (cytotoxicity assays). As mentioned above, a first step
could be to unify our forward dosimetry approach in vitro with
reverse dosimetry approaches in vivo using PBTK modeling,
such as those conducted by Stadnicka-Michalak et al. and
Brinkmann et al.64,73,74 Alternatively, integrated testing
strategies (ITSs) could be utilized in the short term to evolve
the field until the QIVIVE criteria are met. Here, the FET
could be exploited within the AOP concept to bridge the gap
between MIE and low-tier KE, as recorded in vitro, to AO on
the individual level, as recorded with the AFT.
Considerably, the AFT suffers from its restrictions and
pitfalls (no mechanistic information, a broad range of test
species, limited replication, etc.) and would probably not be
validated in its form according to current standards.81,82
Recently, Rawlings et al. explored and suggested the use of the
FET in the threshold approach instead of the AFT.83 Paparella
et al. suggested an integrated approach to testing and
assessment (IATA) for acute fish toxicity, which omits the
AFT as much as possible but instead utilizes the FET and
accompanying NAMs.81 Contextually, with the data and results
in this study, we propose that the FET could be complemented
by fish cell line-based cytotoxicity assays.
This only stands entirely true for baseline toxicants or when
the apical in vivo endpoints are in close mechanistic vicinity to
the measured endpoint of cytotoxicity, as we have seen here,
e.g., for the NR endpoints. As we pointed out earlier, it is not
possible to relate the mechanism of toxicity from apical
endpoints in the AFT, FET, or cytotoxicity assay. Cytotoxicity
assays are assays of nonspecific toxicity and thus record mostly
high-tier cellular effects (KE), which are several levels of
biological complexity above the MIE. Solely, specific and
reactive-toxicity assays, e.g., reporter-gene assays, can define
MIE. Thus, such specific assays are appropriate sentinels for
the assessment, classification, and potential prediction of
MOA.73 Contrarily, most MoAs cannot be related to
cytotoxicity endpoints, with a few exceptions (e.g., baseline
toxicity, uncouplers). Accordingly, even big-data in silico
studies using information derived from the CompTox database
could not relate various in vitro biomarkers of toxicity to
specific MoA even when applying PBTK modeling.84,85
In 2004, Heringa et al. still advocated for measuring real
exposure concentrations69 given that antecedent MBMs were
less refined. Nonetheless, they have anticipated a development
that could turn most chemical concentration analyses obsolete
in the future.31 In this study, we have shown the reliability and
robustness of fish-derived cytotoxicity assays accompanied by
state-of-the-science MBMs to predict effects in the FET and
thus low-tier in vivo assays. If the FET is used as a linking
platform in ITS and IATA, fish cytotoxicity assays could be
utilized in future regulatory decision making (see also
Supporting Information 1, Section 2.5 for a discussion of
numerical estimate values from a risk assessment perspective).
Furthermore, these approaches might facilitate the develop-
ment of novel test systems to pave the way for QIVIVE in
ecotoxicology. The described strategy is merging the strengths
of the in vitro and in silico techniques, thereby covering all
paradigms of the classic (reduction, replacement, refinement)9
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(18) Straḧle, U.; Scholz, S.; Geisler, R.; Greiner, P.; Hollert, H.;
Rastegar, S.; Schumacher, A.; Selderslaghs, I.; Weiss, C.; Witters, H.;
Braunbeck, T. Zebrafish Embryos as an Alternative to Animal
experimentsA Commentary on the Definition of the Onset of
Protected Life Stages in Animal Welfare Regulations. Reprod. Toxicol.
2012, 33, 128−132.
(19) OECD. Test No. 203: Fish, Acute Toxicity Test; OECD
Guidelines for the Testing of Chemicals, Section 2; OECD, 2019.
DOI: 10.1787/9789264069961-en.
(20) Lammer, E.; Carr, G. J.; Wendler, K.; Rawlings, J. M.; Belanger,
S. E.; Braunbeck, T. Is the Fish Embryo Toxicity Test (FET) with the
Zebrafish (Danio Rerio) a Potential Alternative for the Fish Acute
Toxicity Test? Comp. Biochem. Physiol. Part C Toxicol. Pharmacol.
2009, 149, 196−209.
(21) Knob́el, M.; Busser, F. J. M.; Rico-Rico, Á.; Kramer, N. I.;
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Hermens, J. L. M. Quantifying Processes Determining the Free
Concentration of Phenanthrene in Basal Cytotoxicity Assays. Chem.
Res. Toxicol. 2012, 25, 436−445.
(31) Groothuis, F. A.; Heringa, M. B.; Nicol, B.; Hermens, J. L. M.;
Blaauboer, B. J.; Kramer, N. I. Dose Metric Considerations in in Vitro
Assays to Improve Quantitative in Vitro−in Vivo Dose Extrapolations.
Toxicology 2015, 332, 30−40.
(32) Riedl, J.; Altenburger, R. Physicochemical Substance Properties
as Indicators for Unreliable Exposure in Microplate-Based Bioassays.
Chemosphere 2007, 67, 2210−2220.
(33) Hestermann, E. V.; Stegeman, J. J.; Hahn, M. E. Cell Culture
Serum Alters the Uptake and Relative Potencies of Halogenated
Aromatic Hydrocarbons in PLHC-1 Cells. Mar. Environ. Res. 2000,
50, 545−546.
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